• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ICTH 调控突变葡萄糖脑苷脂酶的降解:对戈谢病的影响。

ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease.

机构信息

Department of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.

出版信息

Hum Mol Genet. 2013 Apr 1;22(7):1316-27. doi: 10.1093/hmg/dds535. Epub 2012 Dec 18.

DOI:10.1093/hmg/dds535
PMID:23255161
Abstract

Inability to properly degrade unfolded or misfolded proteins in the endoplasmic reticulum (ER) leads to ER stress and unfolded protein response. This is particularly important in cases of diseases in which the mutant proteins undergo ER-associated degradation (ERAD), as in Gaucher disease (GD). GD is a genetic, autosomal recessive disease that results from mutations in the GBA1 gene, encoding the lysosomal enzyme acid β-glucocerebrosidase (GCase). We have shown that mutant GCase variants undergo ERAD, the degree of which is a major determinant of disease severity. Most ERAD substrates undergo polyubiquitination and proteasomal degradation. Therefore, one expects that mutant GCase variants are substrates for several E3 ubiquitin ligases in different cells. We tested the possibility that ITCH, a known E3 ubiquitin ligase, with a pivotal role in proliferation and differentiation of the skin, recognizes mutant GCase variants and mediates their polyubiquitination and degradation. Our results strongly suggest that ITCH interacts with mutant GCase variants and mediates their lysine 48 polyubiquitination and degradation.

摘要

内质网(ER)中未折叠或错误折叠蛋白质的正确降解能力下降会导致内质网应激和未折叠蛋白反应。在某些情况下,突变蛋白经历 ER 相关降解(ERAD),例如戈谢病(GD),这一点尤为重要。GD 是一种遗传性常染色体隐性疾病,由编码溶酶体酶酸性β-葡糖苷脑苷脂酶(GCase)的 GBA1 基因突变引起。我们已经表明,突变 GCase 变体经历 ERAD,其程度是疾病严重程度的主要决定因素。大多数 ERAD 底物经历多聚泛素化和蛋白酶体降解。因此,可以预期突变 GCase 变体是不同细胞中几种 E3 泛素连接酶的底物。我们测试了已知在皮肤增殖和分化中起关键作用的 E3 泛素连接酶 ITCH 是否识别突变 GCase 变体并介导其多泛素化和降解的可能性。我们的结果强烈表明 ITCH 与突变 GCase 变体相互作用,并介导其赖氨酸 48 多泛素化和降解。

相似文献

1
ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease.ICTH 调控突变葡萄糖脑苷脂酶的降解:对戈谢病的影响。
Hum Mol Genet. 2013 Apr 1;22(7):1316-27. doi: 10.1093/hmg/dds535. Epub 2012 Dec 18.
2
Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease.Parkin 与突变型葡萄糖脑苷脂酶变异体的相互作用:帕金森病与戈谢病之间的可能联系。
Hum Mol Genet. 2010 Oct 1;19(19):3771-81. doi: 10.1093/hmg/ddq292. Epub 2010 Jul 19.
3
Gaucher disease paradigm: from ERAD to comorbidity.戈谢病发病机制:从内质网相关降解途径到共病。
Hum Mutat. 2012 Oct;33(10):1398-407. doi: 10.1002/humu.22124. Epub 2012 Jun 11.
4
ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease.ERdj3是一种与戈谢病相关的突变型葡糖脑苷脂酶变体的内质网降解因子。
Chem Biol. 2014 Aug 14;21(8):967-76. doi: 10.1016/j.chembiol.2014.06.008.
5
Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS.帕金蛋白介导的突变型葡萄糖脑苷脂酶泛素化导致其与底物PARIS和ARTS发生竞争。
Orphanet J Rare Dis. 2014 Jun 16;9:86. doi: 10.1186/1750-1172-9-86.
6
The relationship between glucocerebrosidase mutations and Parkinson disease.葡萄糖脑苷脂酶突变与帕金森病之间的关系。
J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10.
7
Unfolded protein response in Gaucher disease: from human to Drosophila.戈谢氏病中的未折叠蛋白反应:从人类到果蝇。
Orphanet J Rare Dis. 2013 Sep 11;8:140. doi: 10.1186/1750-1172-8-140.
8
Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant.L444P 突变葡萄糖脑苷脂酶变异体的 ERAD 过程的表征。
Blood Cells Mol Dis. 2011 Jan 15;46(1):4-10. doi: 10.1016/j.bcmd.2010.10.012. Epub 2010 Nov 23.
9
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.内质网滞留与降解作为戈谢病异质性的分子基础。
Hum Mol Genet. 2005 Aug 15;14(16):2387-98. doi: 10.1093/hmg/ddi240. Epub 2005 Jul 6.
10
Alteration of the proteostasis network of plant cells promotes the post-endoplasmic reticulum trafficking of recombinant mutant (L444P) human β-glucocerebrosidase.植物细胞蛋白质稳态网络的改变促进了重组突变型(L444P)人β-葡萄糖脑苷脂酶在内质网后的运输。
Plant Signal Behav. 2014;9(3):e28714. doi: 10.4161/psb.28714. Epub 2014 Apr 8.

引用本文的文献

1
Different and unusual presentation of Gaucher's disease with the same mutation in the glucocerebrosidase enzyme (F266L) in two patients: a case report.两名患者患有同一种葡萄糖脑苷脂酶(F266L)突变的戈谢病的不同且不常见表现:病例报告。
J Med Case Rep. 2024 Nov 21;18(1):563. doi: 10.1186/s13256-024-04902-8.
2
Animal Models for the Study of Gaucher Disease.用于戈谢病研究的动物模型。
Int J Mol Sci. 2023 Nov 7;24(22):16035. doi: 10.3390/ijms242216035.
3
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy.
携带 L444P 变异的阿尔法-突触核蛋白 mRNA 水平在接受酶替代治疗的携带者和戈谢病患者中发现存在依赖性。
Biomolecules. 2023 Apr 3;13(4):644. doi: 10.3390/biom13040644.
4
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.神经元型戈谢病:超越溶酶体功能障碍
Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022.
5
TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.TRIP12 泛素化葡萄糖脑苷脂酶导致帕金森病的神经退行性变。
Neuron. 2021 Dec 1;109(23):3758-3774.e11. doi: 10.1016/j.neuron.2021.09.031. Epub 2021 Oct 12.
6
Exploring genetic modifiers of Gaucher disease: The next horizon.探索戈谢病的遗传修饰因子:下一个前沿。
Hum Mutat. 2018 Dec;39(12):1739-1751. doi: 10.1002/humu.23611. Epub 2018 Sep 11.
7
Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity.溶酶体酶葡萄糖脑苷脂酶可抵御β淀粉样蛋白1-42寡聚体诱导的神经毒性。
PLoS One. 2015 Dec 2;10(12):e0143854. doi: 10.1371/journal.pone.0143854. eCollection 2015.
8
Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation.戈谢病中的突变型葡萄糖脑苷脂酶将Hsp27募集到Hsp90伴侣复合体以进行蛋白酶体降解。
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1137-42. doi: 10.1073/pnas.1424288112. Epub 2015 Jan 12.
9
Enzyme enhancers for the treatment of Fabry and Pompe disease.用于治疗法布里病和庞贝病的酶增强剂。
Mol Ther. 2015 Mar;23(3):456-64. doi: 10.1038/mt.2014.224. Epub 2014 Nov 20.
10
Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.戈谢病:代谢缺陷、病理生理学、表型及自然史
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1(0 1):72-81.